by David Maiorana | Jul 15, 2022 | PTAB News, Trial Institution
By David Linden and Dave Maiorana – On June 21, USPTO Director Kathi Vidal issued a memorandum concerning the PTAB’s practice of determining whether to institute an AIA post-grant proceeding in view of the Fintiv factors. The memorandum is in part a result of...
by Matthew Johnson | Jul 1, 2022 | PTAB News, Trial Institution
By Evan Jones, Nicole Newman,* and Matt Johnson – On May 9, 2022, the Patent Trial and Appeal Board denied Hillman Group, Inc.’s (“Hillman’s”) three petitions for inter partes review. See The Hillman Group, Inc. v. Hy-Ko Products Co. LLC, IPR2022-00168, -00169,...
by Matthew Johnson | Jun 23, 2022 | PTAB News, Trial Institution
By Pranita Dhungana,* Christian Roberts, and Matt Johnson – U.S. Patent and Trademark Office (“USPTO”) Director Vidal is initiating sua sponte review of the Patent Trial and Appeal Board’s (“PTAB”) decisions to institute inter partes review of two patents owned...
by Matthew Johnson | Jun 17, 2022 | PTAB News, Trial Institution
By Matt Johnson – On June 16, Senators Leahy, Cornyn, and Tillis introduced the PTAB Reform Act of 2022. The full text of the bill is available here. And a section-by-section recap is accessible here. Senator Leahy said: “I’m proud to continue the work of...
by Matthew Johnson | Jun 2, 2022 | PTAB News, Trial Institution
By Hannah Mehrle and Matt Johnson – F5 Networks, Inc. (“Petitioner”) filed a Petition requesting an IPR. WSOU Investments, LLC d/b/a/ Brazos Licensing and Development (“Patent Owner”) filed a Preliminary Response. Here, the PTAB exercised its discretion under...
by Sarah Geers | Apr 27, 2022 | PTAB News, Trial Institution
By Sarah Geers – The PTAB recently issued a rare decision instituting a derivation proceeding, in Global Health Solutions LLC v. Selner, DER2017-00031 (“GHC”). The GHC institution decision provides several lessons for future petitioners looking to avoid...
